[Correspondence] #Antibody #neutralisation of emerging #SARS-CoV-2 #subvariants: #EG51 and #XBC16 https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(23)00555-8/fulltext?rss=yes #research #covid19 #australia